Board Changes

RNS Number : 7669V

Dechra Pharmaceuticals PLC

08 November 2010

 



Issued by Citigate Dewe Rogerson, Birmingham

Date: Monday 8 November 2010

Dechra^® Pharmaceuticals PLC

("Dechra" or "the Group") 

Board Changes

Director Appointment:

International Veterinary Pharmaceuticals business, Dechra is pleased to announce the appointment of Dr Chris Richards as an Independent Non Executive Director effective from 1 December 2010.

Chris has extensive international experience gained over a successful 27-year career within Life Sciences and technology-driven companies. He is Chairman of Arysta LifeScience Corporation, the world's largest privately owned crop protection company, having been appointed its President and Chief Executive Officer from 2004 to 2009.  Beforejoining Arysta LifeScience, Chris spent 20 years in international management and leadership roles with Syngenta Crop Protection and its predecessor companies.

Commenting on the appointment, Mike Redmond, Chairman at Dechra said:

"On behalf of the Board, I welcome Chris to the team. His international experience gained in the Americas and Asia, as well as in Europe, coupled with his knowledge and expertise within the M&A and complex regulatory environments will be invaluable to our teams as we continue to develop our international footprint and product offering."

Chris will be a member of the Group's Audit, Remuneration and Nomination Committees.

There are no other matters which require to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.

Director Retirement:

Dechra also confirms Senior Independent Non-Executive Director and Chairman of the Remuneration Committee, Malcolm Diamond MBE retired on 5 November 2010.

Mike Redmond, Chairman of Dechra Pharmaceuticals PLC, said:

"Following 10 years of service to the business, on behalf of all colleagues, staff and shareholders, I would like to thank Malcolm for his valued support, contribution and wise counsel. We wish Malcolm and his family all the very best for the future."

With immediate effect, Neil Warner will undertake the role of Senior Independent Non Executive Director on the Group's Board and Bryan Morton will assume the role as Chairman of the Group's Remuneration Committee.

Enquiries:
Ian Page, Chief Executive	Fiona Tooley, Director
Simon Evans, Group Finance Director	Keith Gabriel, Senior Account Manager
Dechra Pharmaceuticals PLC	Citigate Dewe Rogerson
Telephone: + 44 (0) 1782 771100	Telephone: [phone]
Mobile: [phone] (IP)	Mobile: [phone] (FT)
Mobile: [phone] (SE)
www.dechra.com	Ticker: Premium Listing (Pharmaceuticals): DPH

Trademarks appear throughout this release in italics.  Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

BOAEAXFPELDEFEF